ADRX

ADARx Pharmaceuticals Inc

20.64

Sep 29 • 3:59 PM ET +0.55 (2.71%)

20.63

Aftermarket • 7:30 PM ET -0.01 (-0.02%)

Healthcare Biotechnology USA Small NASD

Held by: TMED TDNA TSEE

Scroll to Statements

Index	-
Market Cap	1.56B
Enterprise Value	1.49B
Income	-
Sales	-
Book/sh	-2.35
Cash/sh	5.67
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	-
IPO	Sep 25, 2026

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	-
P/C	3.64
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	12.98
Current Ratio	12.98
Debt/Eq	0.06
LT Debt/Eq	0.05
Option/Short	No / Yes

EPS (ttm)	-
EPS next Y	-
EPS next Q	-
EPS this Y	-
EPS next Y	-
EPS next 5Y	-
EPS past 3/5Y	- -
Sales past 3/5Y	- -
EPS Y/Y TTM	-
Sales Y/Y TTM	-
EPS Q/Q	-
Sales Q/Q	-
Earnings	-
EPS/Sales Surpr.	- -

Insider Own	11.11%
Insider Trans	61.82%
Inst Own	-
Inst Trans	-
ROA	-
ROE	-
ROIC	-
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	3.05%
SMA50	3.05%
SMA200	3.05%
Trades

Shs Outstand	106.80M
Shs Float	94.94M
Short Float	-
Short Ratio	-
Short Interest	-
52W High	23.21 -11.09%
52W Low	18.50 11.54%
Volatility	- -
ATR (14)	3.16
RSI (14)	-
Beta	-
Rel Volume	0.48
Avg Volume	2.71M
Volume	1,299,376

Perf Week	-
Perf Month	-
Perf Quarter	-
Perf Half Y	-
Perf YTD	-6.63%
Perf Year	-
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Recom	-
Target Price	-
Prev Close	20.09
Price	20.64
Change %	2.71%

ADARx Pharmaceuticals, Inc. is a late-clinical-stage biotechnology company. It focuses on developing next-generation small interfering RNA (siRNA) therapeutics for diseases with significant unmet medical needs. The company was founded by Zhen Li in December 2019 and is headquartered in San Diego, CA.

Co-FounderDr. Zhen Li Ph.D.

Chief Scientific OfficerDr. Robert A. MacLeod Ph.D.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
SR ONE CAPITAL MANAGEMENT, LLC	10% Owner	Sep 28 '26	Buy	17.00	1,600,000	27,200,000	5,554,094	Sep 29 09:45 PM
George Simeon	Director	Sep 28 '26	Buy	17.00	1,600,000	27,200,000	5,554,094	Sep 29 09:43 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ADRX

ADARx Pharmaceuticals Inc

Upgrade your Finviz experience